Description

2-[4-(Difluoromethyl)-6-(4-Methoxyphenyl)-3-Methyl-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the research and synthesis of novel drug molecules, especially in oncology and anti-inflammatory therapeutic areas.
• Chemical Research & Development: Serves as a specialized building block for constructing complex pyrazolopyridine-based libraries for high-throughput screening and structure-activity relationship (SAR) studies.
• Agrochemical Research: Potential use as an intermediate in the development of new crop protection agents and herbicides due to its unique difluoromethyl and heterocyclic components.
• Material Science: Investigated for the synthesis of organic electronic materials and specialty polymers where its conjugated system can be leveraged.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects requiring high-purity, complex intermediates.

Basic Information

Product Name	2-[4-(Difluoromethyl)-6-(4-Methoxyphenyl)-3-Methyl-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid
CAS No.	937607-18-6
Molecular Formula	C19H17F2N3O3
Molecular Weight	373.36 g/mol
Synonyms	2-[4-(Difluoromethyl)-6-(4-methoxyphenyl)-3-methylpyrazolo[3,4-b]pyridin-1-yl]acetic acid; 1H-Pyrazolo[3,4-b]pyridine-1-acetic acid, 4-(difluoromethyl)-6-(4-methoxyphenyl)-3-methyl-; 937607-18-6; Difluoromethyl Methoxyphenyl Methylpyrazolopyridine Acetic Acid; Pyrazolopyridine Acetic Acid Derivative; Pharmaceutical Intermediate 937607-18-6
EINECS	Contact for details

Quality Control

Our 2-[4-(Difluoromethyl)-6-(4-Methoxyphenyl)-3-Methyl-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high-purity standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from strong acids and organic solvents. The container must be kept tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.